文献速递肝病消化内镜

美国肝硬化患者减重手术结局的全国性评估

Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
PubMed 文献 · Am J Gastroenterol · 2020-01-01

基于2004至2016年全国住院样本中1,679,828例减重手术入院分析,肝硬化患者占0.58%(9,802例),其院内死亡率(1.81% vs 0.17%)、急性肾损伤(4.5% vs 1.2%)、出血(2.9% vs 1.1%)及手术并发症(2% vs 0.6%)均显著高于无肝硬化者(P<0.001)。限制型手术占比从12%增至71%,两组并发症率均呈下降趋势;但肝硬化患者在低容量中心(年手术量<50例)及非限制型手术中院内死亡风险显著升高(调整OR分别为4.50和4.00)。

要点

  • 肝硬化患者减重手术院内死亡率1.81%,显著高于无肝硬化者0.17%。
  • 低容量中心(<50例/年)肝硬化患者院内死亡调整OR为4.50。
  • 非限制型手术肝硬化患者院内死亡调整OR为4.00。

核心结论

  • 减重手术中限制型手术占比增加且并发症与死亡率呈下降趋势,但肝硬化患者尤其低容量中心者结局风险显著更高。

研究设计与样本

  • 基于美国全国住院样本(NIS)2004至2016年的 population-based 研究,使用ICD-9和ICD-10-CM编码提取减重手术入院,按肝硬化状态、手术类型和中心容量分组。
  • 共纳入1,679,828例减重手术入院,其中肝硬化9,802例(0.58%)。

主要发现

  • 肝硬化患者院内死亡率1.81% vs 无肝硬化0.17%,急性肾损伤4.5% vs 1.2%,出血2.9% vs 1.1%,手术并发症2% vs 0.6%(P均<0.001)。
  • 肝硬化患者更多为白人男性,Elixhauser指数更高。
  • 限制型手术数量从12%增长至71%,两组并发症率均呈下降趋势。
  • 低容量中心(<50例/年)肝硬化患者院内死亡调整OR 4.50(95%CI 3.14-6.45)。
  • 非限制型手术肝硬化患者院内死亡调整OR 4.00(95%CI 2.68-5.97)。

临床怎么用

  • 肝硬化患者行减重手术应优先选择限制型术式,并避免在年手术量<50例的低容量中心实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: With increasing burden of obesity and liver disease in the United States, a better understanding of bariatric surgery in context of cirrhosis is needed. We described trends of hospital-based outcomes of bariatric surgery among cirrhotics and determined effect of volume status and type of surgery on these outcomes. METHODS: In this population-based study, admissions for bariatric surgery were extracted from the National Inpatient Sample using International Classification of Diseases, 9th and 10th Revision, Clinical Modification codes from 2004 to 2016 and grouped by cirrhosis status, type of bariatric surgery, and center volume. In-hospital mortality, complications, and their trends were compared between these groups using weighted counts, odds ratios [ORs], and logistic regression. RESULTS: Among 1,679,828 admissions for bariatric surgery, 9,802 (0.58%) had cirrhosis. Cirrhosis admissions were more likely to be in white men, had higher Elixhauser Index, and higher in-hospital complications rates including death (1.81% vs 0.17%), acute kidney injury (4.5% vs 1.2%), bleeding (2.9% vs 1.1%), and operative complications (2% vs 0.6%) (P < 0.001 for all) compared to those without cirrhosis. Overtime, restrictive surgeries have grown in number (12%-71%) and complications rates have trended down in both groups. Cirrhotics undergoing bariatric surgery at low-volume centers (<50 procedures per year) and nonrestrictive surgery had a higher inpatient mortality rate (adjusted OR 4.50, 95% confidence interval 3.14-6.45, adjusted OR 4.00, 95% confidence interval 2.68-5.97, respectively). DISCUSSION: Contemporary data indicate that among admissions for bariatric surgery, there is a shift to restrictive-type surgeries with an improvement in-hospital complications and mortality. However, patients with cirrhosis especially those at low-volume centers have significantly higher risk of worse outcomes (see Visual abstract, Supplementary Digital Content, http://links.lww.com/AJG/B648).

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Are VS, Knapp SM, Banerjee A, et al. Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment. Am J Gastroenterol. 2020. PMID: 33156104. doi:10.14309/ajg.0000000000000911

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。